About us
NANOLEK is a modern, fast-growing Russian biopharmaceutical company, specializing in the production of import-substituting and innovative drugs. Our high-tech full-cycle production facilities fully comply with GMP and ISO standards. Our portfolio features products both developed in-house and created with international partners. NANOLEK focuses on the prevention and treatment of socially significant diseases.
Today, the company is a leader in the production of pediatric vaccines in Russia. NANOLEK's diversified medicinal product portfolio features therapeutic areas including vaccines, drugs for treatment of HIV, cancer, and other diseases.
NANOLEK HAS A UNIQUE EXPERIENCE IN TECHNOLOGY TRANSFER AS PART OF OUR PARTNERSHIP WITH THE GLOBAL PHARMACEUTICAL LEADERS
A modern fast-growing Russian biopharmaceutical company
Partnership with global pharmaceutical leaders
A committed team of professionals
Unique experience in vaccine technology transfer, manufacturing, and commercialization
A diversified product portfolio formed under strategic partnerships and proprietary developments
A high-tech full-cycle production facility compliant with GMP and ISO 9001
>800
employees, 35% of whom specialize in biotechnology
23
products in the portfolio
>20
products under development
MANUFACTURE OF VACCINES AND BIOLOGICAL DRUGS
42 M
pre-filled
syringes a year
35 M
vials a year
(solutions/suspensions)
2 M
vials a year
(lyophilized products)
PRODUCTION OF SOLID DOSAGE FORMS
4 B
tablets a year
250 M
capsules a year
NANOLEK is a member of associations:
NANOLEK IS THE MOST HIGHLY RATED PROVIDER AND PRIZE WINNER
